User profiles for Samy Suissa
Samy SuissaMcGill University Verified email at mcgill.ca Cited by 87333 |
Immortal time bias in pharmacoepidemiology
S Suissa - American journal of epidemiology, 2008 - academic.oup.com
Immortal time is a span of cohort follow-up during which, because of exposure definition, the
outcome under study could not occur. Bias from immortal time was first identified in the …
outcome under study could not occur. Bias from immortal time was first identified in the …
Metformin and the risk of cancer: time-related biases in observational studies
OBJECTIVE Time-related biases in observational studies of drug effects have been described
extensively in different therapeutic areas but less so in diabetes. Immortal time bias, time-…
extensively in different therapeutic areas but less so in diabetes. Immortal time bias, time-…
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
… Samy Suissa, professor of epidemiology and biostatistics1… Suissa S. Effectiveness of
inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in …
inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in …
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
Background The long-term natural history of chronic obstructive pulmonary disease (COPD)
in terms of successive severe exacerbations and mortality is unknown. Methods The authors …
in terms of successive severe exacerbations and mortality is unknown. Methods The authors …
Immortal time bias in observational studies of drug effects
S Suissa - Pharmacoepidemiology and drug safety, 2007 - Wiley Online Library
Purpose Recent observational studies suggest that various drugs are remarkably effective
at reducing morbidity and mortality. These cohort studies used a flawed approach to design …
at reducing morbidity and mortality. These cohort studies used a flawed approach to design …
The case-time-control design
S Suissa - Epidemiology, 1995 - journals.lww.com
Assessing the known or intended effects of a drug using non-experimental epidemiologic
designs is often infeasible because of the absence of accurate data on a major confounder, the …
designs is often infeasible because of the absence of accurate data on a major confounder, the …
Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly
…, Y Robitaille, JF Boivin, S Suissa - American journal of …, 1993 - academic.oup.com
To determine the frequency of and risk factors fo falls and injurious falls in the noninstitutionalized
elderly, the authors conducted a follow-up study of 409 community-dwelling persons …
elderly, the authors conducted a follow-up study of 409 community-dwelling persons …
[HTML][HTML] Low-dose inhaled corticosteroids and the prevention of death from asthma
Background Although inhaled corticosteroids are effective for the treatment of asthma, it is
uncertain whether their use can prevent death from asthma. Methods We used the …
uncertain whether their use can prevent death from asthma. Methods We used the …
[HTML][HTML] The use of β-agonists and the risk of death and near death from asthma
Background. Morbidity and mortality from asthma appear to be increasing, and it has been
suggested that medications used to treat asthma are contributing to this trend. We …
suggested that medications used to treat asthma are contributing to this trend. We …
Use of gastric acid–suppressive agents and the risk of community-acquired Clostridium difficile–associated disease
ContextRecent reports suggest an increasing occurrence and severity of Clostridium difficile–associated
disease. We assessed whether the use of gastric acid–suppressive agents is …
disease. We assessed whether the use of gastric acid–suppressive agents is …